Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
- DOI
- 10.1093/ofid/ofad354
- Published
- 2023-07-14
- Container
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ofid/ofad354,
title = {Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial},
author = {Adrienne E Shapiro and Elias Sarkis and Jude Acloque and Almena Free and Yaneicy Gonzalez-Rojas and Rubaba Hussain and Erick Juarez and Jaynier Moya and Naval Parikh and David Inman and Deborah Cebrik and Ahmed Nader and Nadia Noormohamed and Qianwen Wang and Andrew Skingsley and Daren Austin and Amanda Peppercorn and Maria L Agostini and Sergio Parra and Sophia Chow and Erik Mogalian and Phillip S Pang and David K Hong and Jennifer E Sager and Wendy W Yeh and Elizabeth L Alexander and Leah A Gaffney and Anita Kohli},
year = {2023},
journal = {Open Forum Infectious Diseases},
doi = {10.1093/ofid/ofad354},
url = {https://doi.org/10.1093/ofid/ofad354}
}RIS
TY - JOUR TI - Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial AU - Adrienne E Shapiro AU - Elias Sarkis AU - Jude Acloque AU - Almena Free AU - Yaneicy Gonzalez-Rojas AU - Rubaba Hussain AU - Erick Juarez AU - Jaynier Moya AU - Naval Parikh AU - David Inman AU - Deborah Cebrik AU - Ahmed Nader AU - Nadia Noormohamed AU - Qianwen Wang AU - Andrew Skingsley AU - Daren Austin AU - Amanda Peppercorn AU - Maria L Agostini AU - Sergio Parra AU - Sophia Chow AU - Erik Mogalian AU - Phillip S Pang AU - David K Hong AU - Jennifer E Sager AU - Wendy W Yeh AU - Elizabeth L Alexander AU - Leah A Gaffney AU - Anita Kohli PY - 2023 JO - Open Forum Infectious Diseases DO - 10.1093/ofid/ofad354 UR - https://doi.org/10.1093/ofid/ofad354 ER -
APA
Shapiro, A. E., Sarkis, E., Acloque, J., Free, A., Gonzalez-Rojas, Y., Hussain, R., Juarez, E., Moya, J., Parikh, N., Inman, D., Cebrik, D., Nader, A., Noormohamed, N., Wang, Q., Skingsley, A., Austin, D., Peppercorn, A., Agostini, M. L., Parra, S., Chow, S., Mogalian, E., Pang, P. S., Hong, D. K., Sager, J. E., Yeh, W. W., Alexander, E. L., Gaffney, L. A., & Kohli, A. (2023). Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofad354
Source records
- crossref · retrieved 2026-09-25T23:20:07.084Z